Imara
(NASDAQ:IMRA)
$4.30
-0.10[-2.27%]
Last update: 2:10PM (Delayed 15-Minutes)
Get Real Time Here
Day Range4.14 - 4.3852 Wk Range0.97 - 5.26Open / Close4.3 / -Float / Outstanding13.9M / 26.3M
Vol / Avg.39.9K / 3.5MMkt Cap113MP/E-50d Avg. Price3.57
Div / Yield-Payout Ratio-Total Float13.9MEPS-0.18

Imara Stock (NASDAQ:IMRA), Quotes and News Summary

Imara Stock (NASDAQ: IMRA) stock price, news, charts, stock research, profile.

Loading...
Day Range4.14 - 4.3852 Wk Range0.97 - 5.26Open / Close4.3 / -Float / Outstanding13.9M / 26.3M
Vol / Avg.39.9K / 3.5MMkt Cap113MP/E-50d Avg. Price3.57
Div / Yield-Payout Ratio-Total Float13.9MEPS-0.18
InvestorsObserver - Oct 25, 2022, 2:15PM
InvestorsObserver - Oct 24, 2022, 3:17PM
InvestorsObserver - Oct 19, 2022, 7:47AM
InvestorsObserver - Oct 18, 2022, 6:54AM
InvestorPlace - Oct 14, 2022, 12:22PM
TipRanks - Oct 14, 2022, 12:13PM
InvestorPlace - Oct 14, 2022, 10:59AM
InvestorsObserver - Oct 12, 2022, 1:23PM
Seeking Alpha - Sep 29, 2022, 3:06PM
InvestorsObserver - Sep 12, 2022, 9:02AM
InvestorsObserver - Sep 9, 2022, 9:03AM
InvestorsObserver - Sep 8, 2022, 6:58AM
TipRanks - Sep 7, 2022, 9:05AM
InvestorsObserver - Aug 30, 2022, 1:39PM
InvestorsObserver - Apr 26, 2022, 10:26AM
Sector: Health Care.Industry: Pharmaceuticals
Imara Inc is a clinical-stage biopharmaceutical company engaged in developing and commercializing novel therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. Its lead product candidate, tovinontrine (IMR-687), is an oral, highly selective, potent small-molecule inhibitor of phosphodiesterase-9, or PDE9.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-0.180
REV0
Q2 2022Est.ActualSurprise
EPS-0.440
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Imara (IMRA) stock?

A

You can purchase shares of Imara (NASDAQ: IMRA) through any online brokerage.

View our list of the best stock brokerages.

Q

What is the target price for Imara (IMRA) stock?

A

The latest price target for Imara (NASDAQ: IMRA) was reported by SVB Leerink on Wednesday, April 6, 2022. The analyst firm set a price target for 1.00 expecting IMRA to fall to within 12 months (a possible -76.74% downside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Imara (IMRA)?

A

The stock price for Imara (NASDAQ: IMRA) is $4.3 last updated Today at November 28, 2022, 7:10 PM UTC.

Q

Does Imara (IMRA) pay a dividend?

A

There are no upcoming dividends for Imara.

Q

When is Imara (NASDAQ:IMRA) reporting earnings?

A

Imara’s Q3 earnings are confirmed for Tuesday, October 25, 2022.

Q

Is Imara (IMRA) going to split?

A

There is no upcoming split for Imara.

Q

What sector and industry does Imara (IMRA) operate in?

A

Imara is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.